- General information enquiries
- Call 00 800 6 7 8 9 10 11
- E-mail your questions
European Commission
Public Health
Accessibility tools
Service tools
Language selector
- Current languageen
Navigation path
- European Commission
- Public health
- Reference documents
- Register
- Orphan products
- Recombinant human pentraxin-2
Pharmaceuticals - Community Register
Community register of orphan medicinal products | GRANTED |
Product information |
Recombinant human pentraxin-2
| EU orphan designation number: | EU/3/14/1366
|
| Active ingredient: | Recombinant human pentraxin-2 |
| Indication: | Treatment of primary myelofibrosis |
| Sponsor: | FGK Representative Service GmbH
Heimeranstraße 35, D-80339 München, Deutschland |
Public summary of scientific opinion
European Commission procedures |
| Close date procedure | Procedure type | EMEA number | Decision | summary publ | decision docs | annex |
| 21/11/2014 | Orphan designation | EMA/OD/140/14 | (2014)8860 of 19/11/2014 |
CONTACT
EU links
Directorate General Health & Consumers